Haleon plc (HLN)
HLN Stock Price Chart
Explore Haleon plc interactive price chart. Choose custom timeframes to analyze HLN price movements and trends.
HLN Company Profile
Discover essential business fundamentals and corporate details for Haleon plc (HLN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
25 Jul 2022
Employees
24.56k
Website
https://www.haleon.comCEO
Brian James McNamara
Description
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
HLN Financial Timeline
Browse a chronological timeline of Haleon plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Jul 2026
EPS estimate is $0.27, while revenue estimate is $7.43bn.
Dividend declared on 10 Apr 2026
A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend was paid on 14 May 2026.
Earnings released on 25 Feb 2026
EPS came in at $0.26 surpassing the estimated $0.25 by +3.38%, while revenue for the quarter reached $7.51bn , missing expectations by -0.79%.
Earnings released on 30 Oct 2025
EPS came in at $0.14 falling short of the estimated $0.24 by -42.83%, while revenue for the quarter reached $7.52bn , beating expectations by +171.94%.
Dividend declared on 15 Aug 2025
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 18 Sept 2025.
Earnings released on 7 Aug 2025
EPS came in at $0.08 falling short of the estimated $0.24 by -67.33%, while revenue for the quarter reached $7.25bn , beating expectations by +162.40%.
Dividend declared on 25 Apr 2025
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 5 Jun 2025.
Earnings released on 27 Feb 2025
EPS came in at $0.05 falling short of the estimated $25.25 by -99.80%, while revenue for the quarter reached $7.14bn , beating expectations by +161.17%.
Earnings released on 31 Oct 2024
EPS came in at $0.14 surpassing the estimated $0.11 by +27.27%, while revenue for the quarter reached $6.93bn , missing expectations by -37.22%.
Dividend declared on 16 Aug 2024
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 19 Sept 2024.
Earnings released on 1 May 2024
EPS came in at $0.12 surpassing the estimated $0.11 by +9.09%, while revenue for the quarter reached $7.21bn , beating expectations by +94.93%.
Dividend declared on 14 Mar 2024
A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 16 May 2024.
Earnings released on 29 Feb 2024
EPS came in at $6.54 falling short of the estimated $10.27 by -36.32%, while revenue for the quarter reached $7.04bn , beating expectations by +0.05%.
Dividend declared on 24 Aug 2023
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 5 Oct 2023.
Earnings released on 2 Aug 2023
EPS came in at $0.08 falling short of the estimated $0.22 by -63.50%, while revenue for the quarter reached $7.28bn , beating expectations by +3.05%.
Dividend declared on 16 Mar 2023
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 27 Apr 2023.
Earnings released on 2 Mar 2023
EPS came in at $0.21 falling short of the estimated $0.23 by -9.70%, while revenue for the quarter reached $6.78bn , missing expectations by -0.27%.
Earnings released on 20 Sept 2022
EPS came in at $0.22 falling short of the estimated $0.22 by -1.57%, while revenue for the quarter reached $5.92bn , missing expectations by -7.59%.
Earnings released on 31 Dec 2021
EPS came in at $0.11 , while revenue for the quarter reached $3.36bn .
HLN Stock Performance
Access detailed HLN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
